Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

Name: Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
Published: 2025
License: Public Domain

Delcath Systems Inc. · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

colorectal-cancer

refractory metastatic colorectal cancer, melphalan/hds, melphalan/hepatic delivery system, trifluridine-tipiracil, trifluridine-tipiracil (ftd-tpi), trifluridine-tipiracil (ftd-tpi) plus bevacizumab, trifluridine-tipiracil plus bevacizumab, hepatic delivery system, melphalan, liver dominant disease, colorectal cancer, metastatic colorectal cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 852030
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.